Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.912 CHF
−77.98 M CHF
726.16 M CHF
149.09 M
About EVOTEC SE INH O.N.
Sector
CEO
Christian Wojczewski
Headquarters
Hamburg
Website
Founded
1998
ISIN
DE0005664809
FIGI
BBG006TLPSX3
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. The EVT Innovate develops drug discovery projects, assets and platforms, both internally or through academic collaborations. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.
Big pullback and off to new highs?This one had an insane run the last couple month. Here comes the first bigger pullback this year. Is it a sign of weakness? I dont think so. I believe, it was just profits taken.
So I will ride the trend again, and follow the price to where it has never been (with this stock).
Wait how Price reac
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of EVT is 7.418 CHF — it has increased by 10.73% in the past 24 hours. Watch EVOTEC SE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange EVOTEC SE stocks are traded under the ticker EVT.
EVT stock has risen by 6.70% compared to the previous week, the month change is a 23.94% rise, over the last year EVOTEC SE has showed a −58.33% decrease.
We've gathered analysts' opinions on EVOTEC SE future price: according to them, EVT price has a max estimate of 20.69 CHF and a min estimate of 3.76 CHF. Watch EVT chart and read a more detailed EVOTEC SE stock forecast: see what analysts think of EVOTEC SE and suggest that you do with its stocks.
EVT stock is 9.69% volatile and has beta coefficient of 0.93. Track EVOTEC SE stock price on the chart and check out the list of the most volatile stocks — is EVOTEC SE there?
Today EVOTEC SE has the market capitalization of 1.28 B, it has increased by 10.33% over the last week.
Yes, you can track EVOTEC SE financials in yearly and quarterly reports right on TradingView.
EVOTEC SE is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
EVT earnings for the last quarter are −0.21 CHF per share, whereas the estimation was −0.10 CHF resulting in a −100.00% surprise. The estimated earnings for the next quarter are −0.07 CHF per share. See more details about EVOTEC SE earnings.
EVOTEC SE revenue for the last quarter amounts to 174.46 M CHF, despite the estimated figure of 179.76 M CHF. In the next quarter, revenue is expected to reach 210.40 M CHF.
EVT net income for the last quarter is −37.40 M CHF, while the quarter before that showed −91.42 M CHF of net income which accounts for 59.09% change. Track more EVOTEC SE financial stats to get the full picture.
No, EVT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 9, 2024, the company has 5.00 K employees. See our rating of the largest employees — is EVOTEC SE on this list?
Like other stocks, EVT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EVOTEC SE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EVOTEC SE technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EVOTEC SE stock shows the sell signal. See more of EVOTEC SE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.